248 related articles for article (PubMed ID: 15370626)
1. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Goldsmith B
Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
[No Abstract] [Full Text] [Related]
2. Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting.
Burnette PK; Perkins J
Pharmacotherapy; 1992; 12(2):120-31. PubMed ID: 1533280
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy-induced emesis and serotonin antagonists].
Jantunen I; Johansson R
Duodecim; 1991; 107(14):1112-5. PubMed ID: 1670506
[No Abstract] [Full Text] [Related]
4. Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
Kidgell AE; Butcher ME; Brown GW
Cancer Treat Rev; 1990 Sep; 17(2-3):311-7. PubMed ID: 2176933
[No Abstract] [Full Text] [Related]
5. [The use of navoban in the therapy of oncology patients with highly emetic treatments].
Russel AJ
Vopr Onkol; 1995; 41(1):87-90. PubMed ID: 7667952
[No Abstract] [Full Text] [Related]
6. [Efficacy of ondansetron in radiation-induced nausea and vomiting: review of the literature].
Lévy E; Paillarse JM; Votan B
Bull Cancer Radiother; 1994; 81(3):179-85. PubMed ID: 7702901
[TBL] [Abstract][Full Text] [Related]
7. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
Perez EA
Semin Oncol; 1995 Aug; 22(4 Suppl 10):1-2. PubMed ID: 7570049
[No Abstract] [Full Text] [Related]
8. 5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis.
Bremer K
J Cancer Res Clin Oncol; 1991; 117(1):85-7. PubMed ID: 1997476
[No Abstract] [Full Text] [Related]
9. The vomiting reflex and the role of 5-HT3 receptors.
Freeman AJ; Bountra C; Dale TJ; Gardner CJ; Twissell DJ
Anticancer Drugs; 1993 Dec; 4 Suppl 2():9-15. PubMed ID: 7511008
[No Abstract] [Full Text] [Related]
10. [Individually risk-adapted antiemetic step therapy].
Bremer K
Dtsch Med Wochenschr; 1994 Apr; 119(16):598-604. PubMed ID: 8162844
[No Abstract] [Full Text] [Related]
11. Interaction of the antiemetics ondansetron and granisetron with the cytotoxicity induced by irradiation, epirubicin, bleomycin, estramustine, and cisplatin in vitro.
Behnam Motlagh P; Henriksson R; Grankvist K
Acta Oncol; 1995; 34(6):871-5. PubMed ID: 7576757
[TBL] [Abstract][Full Text] [Related]
12. An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting.
Sicher K; Backhouse TW
Clin Radiol; 1968 Apr; 19(2):238-40. PubMed ID: 5652468
[No Abstract] [Full Text] [Related]
13. 5-HT3 antagonists in postoperative nausea and vomiting.
Russell D; Kenny GN
Br J Anaesth; 1992; 69(7 Suppl 1):63S-68S. PubMed ID: 1486016
[No Abstract] [Full Text] [Related]
14. Recent advances in the understanding and management of postoperative nausea and vomiting.
Gin T
Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):114-9. PubMed ID: 7710220
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of antiemetics.
Diehl V; Marty M
Cancer Treat Rev; 1994 Oct; 20(4):379-92. PubMed ID: 7954493
[No Abstract] [Full Text] [Related]
16. Ondansetron in the control of chemotherapy-induced and radiotherapy-induced emesis in children with malignancies.
Zoubek A; Kronberger M; Puschmann A; Gadner H
Anticancer Drugs; 1993 Dec; 4 Suppl 2():17-21. PubMed ID: 8136511
[TBL] [Abstract][Full Text] [Related]
17. [Antiemetics in the radiation therapy of tumors].
Legeza VI; Shagoian MG; Kamynina MF; Markovskaia IV
Med Radiol (Mosk); 1988 Mar; 33(3):74-7. PubMed ID: 3280943
[No Abstract] [Full Text] [Related]
18. Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: a summary.
Pintens H
Cancer Treat Rev; 1990 Sep; 17(2-3):307-10. PubMed ID: 2176932
[No Abstract] [Full Text] [Related]
19. Recent developments in the management of emesis with the 5-HT3 antagonist granisetron.
Button D
Semin Oncol Nurs; 1990 Nov; 6(4 Suppl 1):14-9. PubMed ID: 2177568
[No Abstract] [Full Text] [Related]
20. Management of nausea and vomiting in the cancer patient.
Frytak S; Moertel CG
JAMA; 1981 Jan 23-30; 245(4):393-6. PubMed ID: 7452866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
